"Designing Growth Strategies is in our DNA"
The global dermatology drugs market size was USD 36.82 billion in 2019 and is projected to reach USD 63.99 billion by 2027, exhibiting a CAGR of 12.9% during the forecast period.
Currently, a large number of drugs have been approved for the treatment of various dermatologic conditions such as dermatitis, vitiligo, acne, skin cancer, and others. Increasing product launches and rigorous clinical studies are expected to contribute to growth in the global market. Nowadays, acne tends to be a major problem among teenagers concerning their physical appearance. For instance, the American Association of Dermatology states that more than 85% of younger individuals suffer from at least one form of acne. Therefore, increasing prevalence of anti-infective products is expected to drive the demand and sales of dermatology drugs. Moreover, improved marketing strategies of companies and a vast distribution network in order to have a maximum reach of products are likely to contribute to the growing market size during the forecast period.
COVID-19 Pandemic: Reduced Demand for Dermatology Drugs to Dwindle Business Development
The COVID-19 pandemic has negatively impacted the global market as pharmaceutical companies witnessed a setback in the supply chain management owing to the imposition of lockdown by governments of various countries. This led to a reduction in dermatologist appointments. As it is crucial to have a physician’s consultation for skin infections or other dermatology conditions before taking any medications. Stringent social distancing regulations have further led to a decline in market growth. According to the American Association of Dermatology, the dermatologists in the U.S reported an approximately 43% decline in inpatient consultations during the pandemic crisis. Moreover, the reduced demand for products ultimately led to a decrease in sales.
Request a Free sample to learn more about this report.
Increasing U.S Food & Drug Administration Approvals to Attract Business Investments
Despite the tremendous efforts put towards managing dermatology skin conditions, there is a higher demand for the development of low-cost, accurate, and therapeutically effective drugs. The increasing prevalence of acne infections, atopic dermatitis, and other conditions among the population has boosted the pharma companies to manufacture medications targeting skin diseases thus increasing the spending on R&D activities. For example, Alembic pharmaceuticals received a U.S FDA nod for its topical retinoid adapalene gel USP 0.3% indicated for treatment against acne vulgaris.
Increasing Prevalence of Dermatologic Conditions to Propel Product Demand
Globally, an increasing patient population suffering from acne, vitiligo, and dermatitis will strongly lead to an increased demand for novel products. For instance, according to the American Association of Dermatology, in 2018, around 50 million people in the U.S had acne. Therefore, this will consequently boost the demand for effective products to cure the infections. According to Australian research, more than 4% of the population are affected by acne vulgaris in the long term. Thus, a higher prevalence of skin diseases coupled with demand for effective drugs is anticipated to drive the market growth during the forecast period.
Launch of Therapeutically Effective Drugs to Aid Growth
Regular introduction of novel and customer-centric products is likely to have a greater impact on the global dermatology drugs market. For example, in May 2020, Sanofi received U.S FDA approval for its drug Dupixent, is designed for children aged 6 to 11 years against atopic dermatitis. Also, in March 2020, Cosmedix announced the launch of the Correct Rapid Relief product for acne treatment. Additionally, strategies for marketing the product such as website launch, growing awareness campaigns, and advertisements through T.V, social media, and others will aid the market growth during the forecast period.
Risk of Side-effects About Improper Use of Products to Diminish Product Adoption
A major portion of the global population with dermatology infections is contributed by emerging countries owing to improper diet, pollution, and incorrect habitual activities such as smoking, alcohol etc. In low-middle income countries, lack of awareness about skin diseases, and higher illiteracy rate has led to lower adoption of products in the treatment against dermatology conditions. Another factor hindering the market growth is the side-effects associated with the products. For instance, U.S FDA issues an alert for the usage of certain OTC medications that can cause life-threatening allergic conditions. This is likely to lower the adoption of products, leading to a decline in the dermatology drugs’ market value.
To know how our report can help streamline your business, Speak to Analyst
Increased Sales of Products for Acne/ Psoriasis to Foster Growth
Based on the application, the market segments include acne, psoriasis, atopic dermatitis, and others. The psoriasis segment accounts for the majority of the dermatology drugs market share in 2019. High growth of dermatological is attributable to the increased number of manufacturers launching effective drugs. Also, the continuous rise in the prevalence of acne and atopic dermatitis is another factor responsible for the surge in the sales of dermatology drugs. Easy availability of topical solutions at the retail pharmacy has led to intrigued patient population towards the adoption of these products.
Additionally, the acne segment is expected to grow at a considerable CAGR during the forecast period due to the increasing number of market players engaged in introducing advanced products in the global market.
Easy Availability of Topical Solutions to Contribute Revenue Growth
Based on the route of administration, the market for dermatology drugs is classified as oral, parenteral, and topical. The parenteral segment dominated the market in 2019. The dominance of the segment is attributable to the launch of biologics for the treatment of dermatology conditions. Additionally, a rise in the patient preference for topical solutions is expected to surge sales of the products. The oral segment is anticipated to have a significant CAGR during the forecast period owing to U.S FDA approvals for oral treatments.
Growing OTC Products to Contribute Growth of Retail Segment
In terms of the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment holds the lion’s share in the global market owing to increased patient visits and sales of prescription based drugs for treatment against dermatology skin disorders. Also, the rise in the patient preference to buy products from nearby pharmacies, coupled with the availability of low-cost OTC products, is responsible for the growth of this segment. The online pharmacy segment is expected to witness lucrative CAGR over the forecast period owing to penetration of online portals and websites such as amazon, Walmart, etc.
North America Dermatology Drugs Market Size, 2019 (USD Billion)
To get more information on the regional analysis of this market, Request a Free sample
The market size in North America stood at USD 18.08 billion in 2019. The dominance of this region is attributable to the increasing prevalence of dermatology infections. Also, another major factor contributing to the growth of the region is the presence of major players coupled with the launch of products. Europe holds the second position in the market owing to its investments in R&D for the development of effective drugs. This, along with higher sales of dermatology products, is expected to drive the growth during the forecast period. Moreover, Asia Pacific is anticipated to witness the highest CAGR owing to growing awareness among the population about the care & management of acne as well as other conditions. On the other hand, Latin America, and Middle East & Africa are likely to witness comparatively slower growth owing to lower adoption of topical solutions coupled with a lethargic attitude towards the treatment of acne, dermatitis, and other conditions.
To know how our report can help streamline your business, Speak to Analyst
Strong Portfolio and Growth Strategies by Key Players to Improve Business Outcome
The market is consolidated owing to the strong product portfolios and remarkable distribution network of major companies in developed and emerging countries. Currently, Pfizer Inc, BotanixPharma, and Allergan lead the market, accounting for a dominant share in 2019. However, the potential opportunities provided by the market is enabling the entry of several domestic players in the forthcoming years. This will result in a slightly fragmented market by 2027. For example, in December 2019, Ortho Dermatologics received U.S FDA approval for its lotion ARAZLO useful against acne vulgaris.
An Infographic Representation of Dermatology Drugs Market
To get information on various segments, share your queries with us
The global dermatology drugs market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the key market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the advanced market in recent years.
Value (USD Billion)
Application; Route of Administration, Distribution Channel; and Region
By Route of Administration
By Distribution Channel
Fortune Business Insights says that the global market size was USD 36.82 billion in 2019 and is projected to reach USD 63.99 billion by 2027.
In 2019, the North American market stood at USD 18.08 billion.
Growing at a CAGR of 12.9%, the market will exhibit strong growth in the forecast period (2020-2027).
The topical segment is expected to be the leading segment in this market during the forecast period.
The increasing prevalence of dermatology infections such as acne, psoriasis, etc., and the introduction of advanced products by market players are major factors driving the growth of the market.
Pfizer Inc., Botanix Pharmaceuticals, and Allergan are major players in the global market.
North America dominated the market share in 2019.
The increased burden of under-diagnosed skin diseases and the demand for effective products in emerging nations are expected to drive the adoption in the global market.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry